Intersource Medical
Intersource Medical, headquartered in Great Britain, is a leading provider in the medical device industry, specialising in innovative solutions for healthcare professionals. Founded in 2005, the company has established a strong presence across Europe and beyond, focusing on enhancing patient care through advanced medical technologies. The core offerings of Intersource Medical include a range of surgical instruments and medical devices that are distinguished by their quality and reliability. With a commitment to research and development, the company continually seeks to improve its product line, ensuring that healthcare providers have access to the latest advancements. Recognised for its dedication to excellence, Intersource Medical has achieved significant milestones, positioning itself as a trusted partner in the healthcare sector. Its reputation for delivering high-quality products and exceptional customer service has solidified its standing in the competitive medical market.
DitchCarbon Score
How does Intersource Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Intersource Medical's score of 7 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Intersource Medical's reported carbon emissions
Intersource Medical, headquartered in Great Britain, reported a total carbon emissions figure of approximately 73,170 kg CO2e for the year 2022. This total includes 8,770 kg CO2e from Scope 2 emissions and a significant 64,400 kg CO2e from Scope 3 emissions, while Scope 1 emissions were recorded at zero. In the previous year, 2021, the company had total emissions of about 29,300 kg CO2e, with 2,500 kg CO2e from Scope 2 and 26,800 kg CO2e from Scope 3. Despite the increase in total emissions from 2021 to 2022, Intersource Medical has not disclosed any specific reduction targets or initiatives aimed at mitigating their carbon footprint. The absence of documented reduction strategies suggests a need for further commitment to climate action within the industry context.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | |
|---|---|---|
| Scope 1 | - | - |
| Scope 2 | 2,500 | 0,000 |
| Scope 3 | 26,800 | 00,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Intersource Medical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
